A50 — Thomson Medical Cashflow Statement
0.000.00%
Last trade - 00:00- SG$1.56bn
- SG$2.63bn
- SG$394.66m
- 13
- 16
- 99
- 37
Annual cashflow statement for Thomson Medical, fiscal year end - June 30th, SGD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | — | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 26.2 | 69.3 | 55.2 | 30.6 | -40.6 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 21.9 | 21.9 | 28.7 | 18.8 | 76.6 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -4.8 | -16.3 | -16.4 | 6.46 | -14.2 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 61.3 | 92.8 | 88.6 | 83.3 | 60.4 |
| Capital Expenditures | -37.3 | -27.8 | -11.2 | -26.9 | -22.6 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.282 | -1.68 | -2.18 | -463 | -4.58 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Change in Net Intangibles | |||||
| Cash from Investing Activities | -37.6 | -29.4 | -13.4 | -490 | -27.2 |
| Financing Cash Flow Items | -21.2 | -23.3 | -32.3 | -58.6 | -58 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -58.8 | -23.5 | 54.2 | 281 | -71.2 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -35.4 | 38.8 | 125 | -126 | -36.2 |